Kalkulator GI rizika

Odaberite faktore rizika svog pacijenta na NSAIL-u:

H. PYLORI JE NEOVISAN I ADITIVAN FAKTOR RIZIKA.
Pacijentima kojima je potrebna NSAIL terapija može biti od koristi da se se testiraju na H. pylori i po potrebi tretiraju prije početka gastroprotekcije zasnovane na procjeni faktora rizika.

NSAIL: nesteroidni antiinflamatorni lijekovi
ASK: acetilsalicilna kiselina

Lanza FL, Chan FKL, Quigley EMM and the Practice Parameters Committee of the American College of Gastroenterology. Guidelines for Prevention of NSAID-Related Ulcer Complications. Am J Gastroenterol 2009; 104:728 – 738
Gwee KA, Goh V, Lima Get al. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflamatory drugs: risk vs. Benefits, Journal of Pain Research 2018: II 361-374

GI: gastrointestinalni
IPP: inhibitor protonske pumpe
NSAIL: nesteroidni antiinflamatorni lijek

Lanza FL, Chan FKL, Quigley EMM and the Practice Parameters Committee of the American College of Gastroenterology. Guidelines for Prevention of NSAID-Related Ulcer Complications. Am J Gastroenterol 2009; 104:728–738.
Hunt R, B Lazebnik L, C Marakhouski Y, et al. International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G. Euroasian J Hepatogastroenterol. 2018;8(2):148-160. doi:10.5005/jp-journals-10018-1281